Detalhe da pesquisa
1.
Outcomes of definitive local therapy with intensity-modulated radiation therapy in elderly patients ≥70 years with HPV-associated oropharyngeal cancer.
J Med Virol
; 95(12): e29293, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38054393
2.
Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort.
BMC Cancer
; 22(1): 767, 2022 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35836204
3.
Association between Tumor Microbiome and Hypoxia across Anatomic Subsites of Head and Neck Cancers.
Int J Mol Sci
; 23(24)2022 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36555172
4.
Phase I study of the combination of quinacrine and erlotinib in patients with locally advanced or metastatic non small cell lung cancer.
Invest New Drugs
; 36(3): 435-441, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28971268
5.
Emerging risk factors and prevention of perioperative pulmonary complications.
ScientificWorldJournal
; 2014: 546758, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24578647
6.
Palliative Quad Shot Radiation Therapy with or without Concurrent Immune Checkpoint Inhibition for Head and Neck Cancer.
Cancers (Basel)
; 16(5)2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473406
7.
Effectiveness of Nasolacrimal SCC Treatments and Promising Role of Chemo-Induction: A Case Report and Systematic Review.
Laryngoscope
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651346
8.
Scalp Irradiation with 3D-Milled Bolus: Initial Dosimetric and Clinical Experience.
Cancers (Basel)
; 16(4)2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38398079
9.
Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survival.
Cancer Biol Ther
; 25(1): 2350249, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38722731
10.
Immunoprofiles and Oncologic Outcomes of 15 Patients with Androgen Receptor-Positive Salivary Duct Carcinoma.
Cancers (Basel)
; 16(6)2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539538
11.
Patient-reported outcomes in immunotherapy for head and neck cancer.
Head Neck
; 45(7): 1761-1771, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37141438
12.
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35676062
13.
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 28(11): 2329-2338, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344035
14.
Treatment Outcomes of Head and Neck Cancer Patients in the Elderly Receiving Different Chemoradiation Combinations: A Single-Center Experience.
Oncol Res Treat
; 44(10): 521-529, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515190
15.
Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study.
Cancers (Basel)
; 13(5)2021 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33803335
16.
A detailed smoking history and determination of MYC status predict response to checkpoint inhibitors in advanced non-small cell lung cancer.
Transl Lung Cancer Res
; 9(1): 55-60, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32206553
17.
Identification of Clinical and Socioeconomic Predictors of Adjuvant Therapy after Trans-Oral Robotic Surgery in Patients with Oropharyngeal Squamous Cell Carcinoma.
Cancers (Basel)
; 12(9)2020 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32882857
18.
The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
Cancers (Basel)
; 11(8)2019 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31394751
19.
Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer.
Cancer Med
; 8(4): 1459-1466, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30773851
20.
KMT2D Mutation Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 19(4): e489-e501, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29627316